TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aspire Biopharma Holdings ( (ASBP) ) just unveiled an announcement.
On November 4, 2025, Aspire Biopharma Holdings‘ stockholders approved two significant proposals at a Special Meeting. The first proposal granted the board discretionary authority to amend the company’s certificate of incorporation to effect a reverse stock split of common stock within a one-year timeframe. The second proposal approved the issuance of more than 19.99% of outstanding shares upon exercise of Convertible Promissory Notes, adhering to Nasdaq rules, with a specified floor price for conversion.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. operates in the biopharmaceutical industry, focusing on developing innovative therapies to address unmet medical needs.
Average Trading Volume: 22,293,824
Technical Sentiment Signal: Sell
Current Market Cap: $17.18M
For a thorough assessment of ASBP stock, go to TipRanks’ Stock Analysis page.